Combined associations of genetic and environmental risk factors: Implications for prevention of breast cancer

Journal of the National Cancer Institute

Volumn 106, Issue 11, 2014, Pages

  Garcia Closas, Montserrat ^a   Gunsoy, Necdet Burak ^a   Chatterjee, Nilanjan ^b  

^a INSTITUTE OF CANCER RESEARCH   (United Kingdom)

^b NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ESTROGEN; PROGESTERONE; SELECTIVE ESTROGEN RECEPTOR MODULATOR; ANTINEOPLASTIC AGENT; ESTROGEN RECEPTOR; PROGESTERONE RECEPTOR;

BREAST CANCER; CANCER PREVENTION; CHEMOPROPHYLAXIS; ENVIRONMENTAL FACTOR; GENETIC RISK; GENETIC SUSCEPTIBILITY; GENOME-WIDE ASSOCIATION STUDY; GENOTYPE ENVIRONMENT INTERACTION; HORMONAL THERAPY; HUMAN; MENOPAUSE; MULTIFACTORIAL INHERITANCE; PREVENTION STUDY; PRIORITY JOURNAL; REVIEW; RISK ASSESSMENT; RISK BENEFIT ANALYSIS; ADVERSE EFFECTS; BREAST NEOPLASMS; ENVIRONMENTAL EXPOSURE; FEMALE; GENETIC PREDISPOSITION; GENETICS; GREAT BRITAIN; RECEIVER OPERATING CHARACTERISTIC; RISK FACTOR; SINGLE NUCLEOTIDE POLYMORPHISM;

ANTICARCINOGENIC AGENTS; BREAST NEOPLASMS; ENVIRONMENTAL EXPOSURE; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOME-WIDE ASSOCIATION STUDY; GREAT BRITAIN; HUMANS; POLYMORPHISM, SINGLE NUCLEOTIDE; RECEPTORS, ESTROGEN; RECEPTORS, PROGESTERONE; RISK ASSESSMENT; RISK FACTORS; ROC CURVE; SELECTIVE ESTROGEN RECEPTOR MODULATORS;

EID: 84984985158     PISSN: 00278874     EISSN: 14602105     Source Type: Journal    
DOI: 10.1093/jnci/dju305     Document Type: Review

References (35)

1. Burton H, Chowdhury S, Dent T, Hall A, Pashayan N, Pharoah P. Public health implications from COGS and potential for risk stratification and screening. Nat Genet. 2013;45(4):349-351.
2. Pashayan N, Pharoah P. Population-based screening in the era of genomics. Per Med. 2012;9(4):451-455.
3. Rose G. Sick Individuals and Sick Populations. Int J Epidemiol. 1985;14(1):32-38.
4. Cuzick J, Sestak I, Bonanni B, et al. Selective oestrogen receptor modulators in prevention of breast cancer: an updated meta-Analysis of individual participant data. Lancet. 2013;381(9880):1827-1834.
5. Wacholder S, Hartge P, Prentice R, et al. Performance of common genetic variants in breast-cancer risk models. N Engl J Med. 2010;362(11):986-993.
6. Gail MH. Discriminatory accuracy from single-nucleotide polymorphisms in models to predict breast cancer risk. J Natl Cancer Inst. 2008;100(14):1037-1041.
7. Hüsing A, Canzian F, Beckmann L, et al. Prediction of breast cancer risk by genetic risk factors, overall and by hormone receptor status. J Med Genet. 2012;49(9):601-608.
8. Garcia-Closas M, Rothman N, Figueroa JD, et al. Common Genetic Polymorphisms Modify the Effect of Smoking on Absolute Risk of Bladder Cancer. Cancer Res. 2013;73(7):2211-2220.
9. Michailidou K, Hall P, González-Neira A, et al. Large-scale genotyping identifies 41 new loci associated with breast cancer risk. Nat Genet. 2013;45(4):353-361.
10. Garcia-Closas M, Couch FJ, Lindstrom S, et al. Genome-wide association studies identify four ER negative-specific breast cancer risk loci. Nat Genet. 2013;45(4):392-398.
11. Bojesen SE, Pooley KA, Johnatty SE, et al. Multiple independent variants at the TERT locus are associated with telomere length and risks of breast and ovarian cancer. Nat Genet. 2013;45(4):371-384.
12. French JD, Ghoussaini M, Edwards SL, et al. Functional Variants at the 11q13 Risk Locus for Breast Cancer Regulate Cyclin D1 Expression through Long-Range Enhancers. Am J Hum Genet. 2013;92(4):489-503.
13. Mavaddat N, Antoniou AC, Easton DF, Garcia-Closas M. Genetic susceptibility to breast cancer. Mol Oncol. 2010;4(3):174-191.
14. COGS Primer. http://www.nature.com/icogs/primer/common-variationand-heritability-estimates-for-breast-ovarian-And-prostate-cancers/. Accessed May 30, 2013.
15. Tice JA, Cummings SR, Smith-Bindman R, Ichikawa L, Barlow WE, Kerlikowske K. Using clinical factors and mammographic breast density to estimate breast cancer risk: development and validation of a new predictive model. Ann Intern Med. 2008;148(5):337-347.
16. Pharoah PD, Day NE, Duffy S, Easton DF, Ponder BA. Family history and the risk of breast cancer: a systematic review and meta-Analysis. Int J Cancer. 1997;71(5):800-809.
17. Nelson HD, MD, MPH, et al. Risk Factors for Breast Cancer for Women Age 40 to 49: A Systematic Review and Meta-Analysis. Ann Intern Med. 2012;9(156):635-648.
18. McCormack VA, Santos Silva Dos I. Breast density and parenchymal patterns as markers of breast cancer risk: a meta-Analysis. Cancer Epidemiol Biomarkers Prev. 2006;15(6):1159-1169.
19. Hartmann LC, Sellers TA, Frost MH, et al. Benign breast disease and the risk of breast cancer. N Engl J Med. 2005;353(3):229-237.
20. Byrne C, Schairer C, Brinton LA, et al. Effects of mammographic density and benign breast disease on breast cancer risk (United States). Cancer Causes Control. 2001;12(2):103-110.
21. Reeves GK, Pirie K, Green J, Bull D, Beral V, Million Women Study Collaborators. Comparison of the effects of genetic and environmental risk factors on in situ and invasive ductal breast cancer. Int J Cancer. 2012;131(4):930-937.
22. Parkin DM. Is the recent fall in incidence of post-menopausal breast cancer in UK related to changes in use of hormone replacement therapy? Eur J Cancer. 2009;45(9):1649-1653.
23. Gaudet MM, Gapstur SM, Sun J, Diver WR, Hannan LM, Thun MJ. Active smoking and breast cancer risk: original cohort data and meta-Analysis. J Natl Cancer Inst. 2013;105(8):515-525.
24. Cohort Fertility Tables in England and Wales. Office for National Statistics. http://data.gov.uk/dataset/cohort-fertility-england-And-wales. Accessed June 19, 2013.
25. Collaborative Group on Hormonal Factors in Breast Cancer. Menarche, menopause, and breast cancer risk: individual participant meta-Analysis, including 118 964 women with breast cancer from 117 epidemiological studies. Lancet Oncol. 2012;13(11):1141-1151.
26. Alcohol, tobacco and breast cancer-collaborative reanalysis of individual data from 53 epidemiological studies, including 58 515 women with breast cancer and 95 067 women without the disease. Br J Cancer. 2002;87(11):1234-1245.
27. Jacobi CE, Jonker MA, Nagelkerke NJ, van Houwelingen JC, de Bock GH.Prevalence of family histories of breast cancer in the general population and the incidence of related seeking of health care. J Med Genet. 2003;40(7):e83.
28. NICE Familial Breast Cancer: Update of clinical guideline 14 and 41 http://www.nice.org.uk/nicemedia/live/13269/62338/62338.pdf. Accessed January 8, 2013.
29. Darabi H, Czene K, Zhao W, Liu J, Hall P, Humphreys K. Breast cancer risk prediction and individualised screening based on common genetic variation and breast density measurement. Breast Cancer Res. 2012;14(1):R25.
30. Rose G. The Strategy of Preventive Medicine. New York, NY: Oxford University Press; 1992.
31. Milne RL, Gaudet MM, Spurdle AB, et al. Assessing interactions between the associations of common genetic susceptibility variants, reproductive history and body mass index with breast cancer risk in the breast cancer association consortium: a combined case-control study. Breast Cancer Res. 2010;12(6):R110.
32. Campa D, Kaaks R, Le Marchand L, et al. Interactions Between Genetic Variants and Breast Cancer Risk Factors in the Breast and Prostate Cancer Cohort Consortium. J Natl Cancer Inst. 2011;103(16):1252-1263.
33. Travis RC. Gene-environment interactions in 7610 women with breast cancer: prospective evidence from the Million Women Study. 2010:1-13.
34. Nickels S, Truong T, Hein R, et al. Evidence of Gene-Environment Interactions between Common Breast Cancer Susceptibility Loci and Established Environmental Risk Factors. PLoS Genet. 2013;9(3):e1003284.
35. Han SS, Rosenberg PS, Garcia-Closas M, et al. Likelihood Ratio Test for Detecting Gene (G)-Environment (E) Interactions Under an Additive Risk Model Exploiting G-E Independence for Case-Control Data. Am J Epidemiol. 2012;176(11):1060-1067.